BRUFEN 400MG contains Ibuprofen which belongs to the group of medicines called Non-steroidal anti-inflammatory drugs (NSAIDs). It is used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis (juvenile rheumatoid arthritis or Still's disease), arthritis of the spine, ankylosing spondylitis, swollen joints, frozen shoulder, bursitis, tendinitis, tenosynovitis, lower back pain, sprains and strains. This medicine can also be used to manage other painful conditions such as toothache, pain after operations, period pain, headache and migraine.
When your body is fighting an injury or infection, it naturally releases chemicals called prostaglandins which lead to fever, swelling and discomfort. BRUFEN 400MG blocks the effect of prostaglandins.
Before taking BRUFEN 400MG tell your doctor if you have liver, kidney or heart disease. Pregnant and breastfeeding women must consult the doctor before taking this medicine. Avoid excessive use of painkillers, tell your doctor if you are already taking another painkiller before taking this medicine. The common side effects are dizziness, tiredness, headache, diarrhea, constipation and flatulence.
Before taking BRUFEN 400MG tell your doctor if you are already taking another painkiller before taking this medicine tell your doctor if you are currently planning a pregnancy or if you are breastfeeding. This medicine can increase the risk of heart attack, stroke and liver damage. Before taking this medicine, let your doctor know if you are planning to have a baby you have only rarely have a baby who is very, very, very healthy. Before you take this medicine inform your doctor if you are a women. If you are a man.The common side effects are dizziness, tiredness, headache, diarrhea, flatulence and constipation. Get medical attention by researching the signs and symptoms of pregnant women who are taking medication for pain and inflammation, such as ibuprofen. Some women may experience stomach cramps or a sore throat. Consult your doctor if you are a woman. If you are a man, your doctor may prescribe a non-pharmacological painkiller for you.
Taking other medicines may also increase the risk of side effects. Tell your doctor about all the medicines you take including herbal medicines, vitamins and antipsychotic medicines. Your doctor may also recommend research and other treatments for you to seek medical advice if you are taking any other medication. Your doctor will do a blood test to monitor your response to the treatment.
Taking BRUFEN 400MG with alcohol may affect your body’s ability to fight painRead the patient information leaflet provided by the doctor and pharmacist before taking this medicine and if you want more information, then ask the doctor or pharmacist if you have any queries regarding this medicine.
Keep this medicine in a dry place where the temperature stays below 30℃.
You will be notified via email or phone when you are to take this medicine.
You should store this medicine in a cool and dry place where the temperature stays below 30℃.
Keep this medicine in a cool and dry place where the temperature stays below 30℃.
Other medicines and BRUFEN 400MG may interact with each otherThere may be some medicines that affect the action of BRUFEN 400MG. Tell any doctor, dentist or pharmacist who is with you if you have any of the following medical conditions:
A new formulation designed to target the acetaminophen, ibuprofen and naproxen in the body. This formulation combines a combination of two active ingredients: propionic acid and lactose monohydrate. This new formulation is made from natural plant extracts, making it a natural alternative to traditional non-steroidal anti-inflammatory drugs (NSAIDs).
The active ingredient in this formulation is propionic acid and lactose monohydrate. The combination of ingredients is used to provide relief from pain and inflammation. It is formulated with natural plant and mineral products in each formulation.
This new formulation is made from natural plant and mineral products.
Active ingredient:
Formulation:
Ingredients:
Dosage:
Contraindications:
The new formulation is intended for patients who have not responded to NSAIDs alone, such as those with co-existing gastrointestinal conditions, or who have a history of ulceration or perforation in the stomach or intestines.
Special Precautions:
Warnings:
There are a number of drugs in the range of analgesics used in the treatment of musculoskeletal disorders. The main indication is the treatment of acute pain in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain after acute myocardial infarction (AMI). It should be noted that some of these drugs may be used for other purposes, such as prevention of cardiovascular diseases, treatment of infections, prevention of fever, and management of postoperative pain. In this context, the analgesic agents listed below are not limited to these drugs; however, the use of these agents in the treatment of acute pain and the prevention of cardiovascular diseases has also been reported.
The most common analgesic agents used in acute pain include non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, diclofenac, ketoprofen, and other non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are considered to be one of the most important classes of drugs used to treat acute pain. The most common analgesic agents used in acute pain in osteoarthritis include oral non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, diclofenac, ketoprofen, and other non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are also the most widely used analgesics. They are effective in treating acute pain in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain after acute myocardial infarction (AMI). In addition to the non-steroidal anti-inflammatory drugs (NSAIDs), NSAIDs are also indicated to be used as adjunctive therapy in the management of acute pain and the prevention of cardiovascular diseases in patients with diabetes mellitus and/or impaired renal function. These agents are not recommended to be used in patients with a history of gastrointestinal diseases, liver dysfunction, or hepatic impairment.
There are various NSAIDs available as oral formulations. The most commonly used NSAIDs include ibuprofen, naproxen, diclofenac, ketoprofen, and other non-steroidal anti-inflammatory drugs (NSAIDs). These agents are effective in the treatment of acute pain and the prevention of cardiovascular diseases in patients with diabetes mellitus and/or impaired renal function.
For the treatment of acute pain in osteoarthritis, the drug is given in an intravenous infusion and is usually given in tablet form at a fixed rate. The dosing rate is usually 10 mg/day and is determined by the patient's tolerance. In addition, the drug is given once daily in a single dose. The recommended dosing regimen is based on the patient's age and the type and severity of the disease, with the aim of minimizing side effects and increasing the therapeutic effect of the drug. The maximum daily dose for the treatment of osteoarthritis is 100 mg, and the maximum dose of diclofenac is 600 mg. The dosage of ibuprofen and diclofenac is usually 2 to 5 mg per day. The dose of ketoprofen is usually 2.5 to 5 mg per day. For the treatment of acute pain in rheumatoid arthritis, the dosage of ibuprofen and diclofenac is usually 5 to 10 mg per day and is determined by the patient's tolerance and the efficacy of the drug. In addition, the dose of ketoprofen is usually 2.5 to 5 mg per day. For the prevention of cardiovascular diseases, the dosage of ibuprofen is usually 5 to 10 mg per day and is determined by the patient's tolerance and the efficacy of the drug. The dosage of ketoprofen is usually 2.5 to 5 mg per day. For the treatment of acute pain in ankylosing spondylitis, the dose of ibuprofen and diclofenac is usually 5 to 10 mg per day and is determined by the patient's tolerance and the efficacy of the drug.
For the treatment of ankylosing spondylitis, the drug is given in oral tablet form at a fixed dose. The dose is usually 2.5 to 5 mg per day. The maximum daily dose of the drug is 2.5 mg per day. The recommended dose for the treatment of acute pain in ankylosing spondylitis is 10 to 15 mg per day.
Published: 10/12/2020Updated: 07/06/2022
This study was conducted in the UK in collaboration with the National Institute of Health in USA, and the University of Liverpool. The study was approved by the Research Ethics Committee at the University of Liverpool and in accordance with local ethical guidelines. All subjects gave written informed consent prior to participating in the study. The study was registered at ClinicalTrials.gov (NCT registry: NCT01144533) in both English and French. The study was carried out in collaboration with the University of Liverpool. The study protocol was approved by the University of Liverpool, University of Liverpool and the University of Liverpool Research Ethics Committee (Reference number: 13/13/0008).
The aim of the study was to evaluate the effect of ibuprofen on cartilage tissue damage caused by ibuprofen treatment in a clinical trial of patients with cartilage damage. We included patients with mild-to-moderate cartilage damage caused by ibuprofen therapy. We also included patients with moderate-to-severe cartilage damage caused by ibuprofen therapy. We evaluated the effect of ibuprofen on the following parameters: the extent of cartilage damage in the three groups. The percentage of cartilage damage, the extent of the damage, and the extent of the improvement of the cartilage tissue were assessed. Additionally, we evaluated the effect of ibuprofen treatment on the following parameters: the number of cartilage damage, the extent of the damage, and the improvement of cartilage tissue. The primary end points were the proportion of the participants with grade 2 cartilage damage, the percentage of the participants with grade 1 cartilage damage, and the number of participants with grade 3 cartilage damage. For the assessment of cartilage damage, we also evaluated the extent of the damage, the number of cartilage damage, and the number of participants with grade 2 cartilage damage. The analysis of the percentage of cartilage damage, the extent of the damage, and the extent of the improvement of cartilage tissue were also carried out.
All of the statistical analyses were carried out using SPSS software (version 20.0; SPSS, Inc, Chicago, IL, USA). The differences between the groups in the percentage of cartilage damage, the extent of the damage, and the improvement of cartilage tissue were compared using a paired samplet-test and the-test with the Bonferroni correction. Thep-value was calculated by using theP-value (0.05/10) and the-value for the-test with the Bonferroni correction, and theThe differences between groups in the percentage of cartilage damage, the extent of the damage, and the improvement of cartilage tissue were compared using a paired sample
Stade de France Pharmacy